We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

50 hedge funds and large institutions have $81.3M invested in Tempest Therapeutics in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 2

233% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 6

41% more capital invested

Capital invested by funds: $57.5M → $81.3M (+$23.7M)

22% more funds holding

Funds holding: 41 → 50 (+9)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
50
Holders Change
+9
Holders Change %
+21.95%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
11
Increased
20
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$6.03M
2
AIC
AWM Investment Company
New York
+$4.42M
3
SB
Samsara BioCapital
California
+$3.82M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.68M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.62M

Top Sellers

Rank Fund Capital Flow
1
ASP
Adams Street Partners
Illinois
-$403K
2
PM
Prosight Management
Texas
-$370K
3
Wells Fargo
Wells Fargo
California
-$148K
4
Victory Capital Management
Victory Capital Management
Texas
-$10K
5
GC
GMT Capital
Georgia
-$9.87K
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$132K +$141K +100 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$131K – – –
Wells Fargo
28
Wells Fargo
California
$112K -$148K -105 -55%
N
29
Nuveen
North Carolina
$100K – – –
Deutsche Bank
30
Deutsche Bank
Germany
$100K +$90.2K +64 +457%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$97K – – –
Morgan Stanley
32
Morgan Stanley
New York
$85K +$70.5K +50 +333%
UBS Group
33
UBS Group
Switzerland
$78K +$18.3K +13 +28%
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$65K – – –
Barclays
35
Barclays
United Kingdom
$63K +$33.8K +24 +100%
Bank of America
36
Bank of America
North Carolina
$42K -$4.23K -3 -9%
AIG
37
American International Group
New York
$40K – – –
TRCT
38
Tower Research Capital (TRC)
New York
$40K +$43.7K +31 New
CG
39
Cutler Group
California
$19K +$21.1K +15 New
SO
40
STRS Ohio
Ohio
$16K – – –
Legal & General Group
41
Legal & General Group
United Kingdom
$13K +$2.82K +2 +25%
Citigroup
42
Citigroup
New York
$13K +$11.3K +8 +400%
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$9K +$2.82K +2 +40%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$8.76K +$7.05K +5 +250%
CSS
45
Cubist Systematic Strategies
Connecticut
$7K -$1.41K -1 -14%
AIP
46
Ameritas Investment Partners
Nebraska
$6K – – –
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$6K +$5.64K +4 New
PCM
48
Prelude Capital Management
New York
$6K +$7.05K +5 New
PHK
49
Point72 Hong Kong
Hong Kong
$3K +$4.23K +3 New
MAM
50
Meeder Asset Management
Ohio
$2K – – –
1
2
3

TPST Hedge Fund Activity: Q4 2019 in Review

50 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2019, worth a combined $81.3M — up 41% from $57.5M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new TPST positions and 2 closed out — a net gain of 9 holders — while 20 added to existing stakes and 6 trimmed.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $6.03M. The largest seller was Adams Street Partners, cutting an estimated $403K.

  • 50 institutional investors held Tempest Therapeutics (TPST) as of Q4 2019, up from 41 in Q3 2019.
  • Funds reported $81.3M of Tempest Therapeutics stock for Q4 2019, up 41% quarter-over-quarter.
  • 11 funds opened new Tempest Therapeutics positions in Q4 2019 and 2 closed out, a net change of +9 holders.
  • The largest Tempest Therapeutics buyer in Q4 2019 was Baker Bros. Advisors, an estimated $6.03M added.
  • The largest Tempest Therapeutics seller in Q4 2019 was Adams Street Partners, an estimated $403K sold.

Based on aggregated 13F filings for Q4 2019.